Prime Medicine Inc. (PRME) Social Stream
PRIME MEDICINE INC (PRME) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PRME.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
PRME reports an average of 49.97% for its upside potential over the past 118 days.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
PRME Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how PRIME MEDICINE INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 46.68% of that group.
- In terms of how PRIME MEDICINE INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 75.81% of that group.
- In terms of how PRIME MEDICINE INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 67.07% of that group.
- In the context of stocks in the small market cap category, PRIME MEDICINE INC's average analyst price target is higher than 123.51% of them.
In the Pharmaceutical Products industry, CDXC, MTEX, and MNMD are the three stocks most similar to PRIME MEDICINE INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is PRME a Buy, Hold or Sell? See the POWR Ratings now!